Ephraim Resources Limited Stock

Stocks

EPA

AU000000EPA3

Biotechnology & Medical Research

End-of-day quote 07:47:55 28/02/2017 +03 5-day change 1st Jan Change
0.002000 AUD +100.00% Intraday chart for Ephraim Resources Limited +100.00% -

Valuation: Ephraim Resources Limited

Market Cap 3.08M 2.76M 2.55M 2.3M 4.31M 293M 4.38M 30.36M 12.11M 153M 11.56M 11.31M 486M P/E 2017
-6.41x
P/E 2018 -3.16x
Enterprise Value 3.63M 3.25M 3M 2.71M 5.07M 346M 5.16M 35.77M 14.27M 181M 13.62M 13.33M 573M EV / Sales 2017
223x
EV / Sales 2018 29,261x
Free-Float
68.23%
Yield 2017 *
-
Yield 2018 -
Manager TitleAgeSince
President - -
Chief Operating Officer - -
Corporate Secretary 60 28/01/2020
Director TitleAgeSince
Director/Board Member 60 17/01/2020
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
+100.00%+100.00% - - 2.09M
+0.34%-3.03%+37.45%+61.06% 64.14B
+0.98%+2.68%+12.25%+83.90% 55.53B
+1.75%+2.01%+13.30%+105.71% 53.03B
-1.41%-1.39%+25.99%+54.92% 45.99B
-0.88%-3.12%+17.63%+98.46% 42.45B
-0.05%+0.70%+225.75%+929.97% 40.45B
-0.26%-4.20%+10.86%+45.18% 32.25B
-2.07%+42.73%+103.77%+90.26% 34.47B
-2.72%-8.79%+22.58%-5.63% 24.23B
Average +9.53%+13.44%+52.17%+162.65% 39.25B
Weighted average by Cap. -0.25%+3.13%+49.26%+160.33%

Financials

2017 2018
Net sales 16.01K 14.34K 13.23K 11.97K 22.39K 1.52M 22.75K 158K 62.97K 798K 60.08K 58.8K 2.53M 124 111.07 102.47 92.72 173.39 11.81K 176.19 1.22K 487.69 6.18K 465.36 455.45 19.57K
Net income -481K -431K -397K -360K -673K -45.8M -683K -4.74M -1.89M -23.97M -1.8M -1.77M -75.92M -976K -874K -806K -730K -1.36M -92.9M -1.39M -9.62M -3.84M -48.62M -3.66M -3.58M -154M
Net Debt 497K 445K 410K 371K 695K 47.3M 706K 4.9M 1.95M 24.76M 1.86M 1.82M 78.41M 548K 491K 453K 410K 767K 52.22M 779K 5.41M 2.16M 27.33M 2.06M 2.01M 86.55M
Logo Ephraim Resources Limited
Lanka Graphite Ltd is an Australia-based company. The Company is engaged in the business of agricultural biogenetics research and experimentation, licensing and consultancy. The Company focuses on nipah palm breeding, tissue culture, cultivation and plantation, and the conversion of sap from the nipah palm to sugar and ethanol. The Company operates through two segments: Australia and Indonesia.
Employees
-